Peter McIntyre

Summary

Affiliation: The Children's Hospital at Westmead
Country: Australia

Publications

  1. ncbi request reprint Vaccines for other neonatal infections: vaccination strategies for the prevention of neonatal pertussis
    Peter McIntyre
    National Center for Immunization Research and Surveillance of Vaccine Preventable Diseases, University of Sydney, Westmead, New South Wales, Australia
    Expert Rev Vaccines 3:375-8. 2004
  2. pmc Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program
    Suzanne M Garland
    Regional World Health Organisation Human Papillomavirus Laboratory Network, Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Locked Bag 300, Parkville, Victoria 3052, Australia
    BMC Med 9:104. 2011
  3. doi request reprint Pertussis in early infancy: disease burden and preventive strategies
    Peter McIntyre
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Westmead, Australia
    Curr Opin Infect Dis 22:215-23. 2009
  4. doi request reprint Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination
    Peter B McIntyre
    National Centre for Immunisation Research and Surveillance, University of Sydney and The Children s Hospital at Westmead, Australia
    Vaccine 27:1062-6. 2009
  5. ncbi request reprint High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine
    Peter B McIntyre
    Centre for Immunisation Research, University of Sydney and the Royal Alexandra Hospital for Children, Locked Bag 4001, Westmead, NSW 2145, Australia
    Vaccine 23:380-5. 2004
  6. ncbi request reprint Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006
    Robert Menzies
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Australia
    Commun Dis Intell Q Rep 32:S2-67. 2008
  7. doi request reprint Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age
    Nicholas Wood
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead and the University of Sydney, New South Wales, Australia
    Pediatr Infect Dis J 29:209-15. 2010
  8. ncbi request reprint Surveillance of adverse events following immunisation: Australia 2002 to 2003
    Glenda Lawrence
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children s Hospital at Westmead, Westmead, New South Wales
    Commun Dis Intell Q Rep 28:324-38. 2004
  9. ncbi request reprint Annual report: Surveillance of adverse events following immunisation in Australia, 2005
    Glenda Lawrence
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children s Hospital at Westmead, Sydney, New South Wales
    Commun Dis Intell Q Rep 30:319-33. 2006
  10. ncbi request reprint Annual report: surveillance of adverse events following immunisation in Australia, 2008
    Rob Menzies
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney, The Children s Hospital at Westmead, Sydney, New South Wales
    Commun Dis Intell Q Rep 33:365-81. 2009

Collaborators

Detail Information

Publications53

  1. ncbi request reprint Vaccines for other neonatal infections: vaccination strategies for the prevention of neonatal pertussis
    Peter McIntyre
    National Center for Immunization Research and Surveillance of Vaccine Preventable Diseases, University of Sydney, Westmead, New South Wales, Australia
    Expert Rev Vaccines 3:375-8. 2004
    ....
  2. pmc Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program
    Suzanne M Garland
    Regional World Health Organisation Human Papillomavirus Laboratory Network, Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Locked Bag 300, Parkville, Victoria 3052, Australia
    BMC Med 9:104. 2011
    ..Prior to introduction of a national human papilloma virus (HPV) vaccination program, we determined HPV genotype prevalence by Indigenous status and residence in remote areas...
  3. doi request reprint Pertussis in early infancy: disease burden and preventive strategies
    Peter McIntyre
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Westmead, Australia
    Curr Opin Infect Dis 22:215-23. 2009
    ..We review current understanding of the disease burden and potential prevention strategies...
  4. doi request reprint Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination
    Peter B McIntyre
    National Centre for Immunisation Research and Surveillance, University of Sydney and The Children s Hospital at Westmead, Australia
    Vaccine 27:1062-6. 2009
    ..5% and 90.6% of pa vaccine recipients. At 5 years post boosting, antibody levels to diphtheria and tetanus are similar amongst adults receiving a dTpa or dT, and pertussis antibodies remain above pre-booster levels in at least 85%...
  5. ncbi request reprint High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine
    Peter B McIntyre
    Centre for Immunisation Research, University of Sydney and the Royal Alexandra Hospital for Children, Locked Bag 4001, Westmead, NSW 2145, Australia
    Vaccine 23:380-5. 2004
    ..Adult-formulated dTpa vaccines could replace Td for routine booster vaccination of older individuals...
  6. ncbi request reprint Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006
    Robert Menzies
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Australia
    Commun Dis Intell Q Rep 32:S2-67. 2008
    ..Immunisation programs are an example of how preventive health programs in general can be enhanced to close the gap in morbidity and mortality between Indigenous and non-Indigenous Australians...
  7. doi request reprint Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age
    Nicholas Wood
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead and the University of Sydney, New South Wales, Australia
    Pediatr Infect Dis J 29:209-15. 2010
    ..Several studies have examined antibody responses to pertussis vaccines at birth but no previous study has evaluated 2 doses of monovalent acellular pertussis vaccine (aPV) before 2 months of age...
  8. ncbi request reprint Surveillance of adverse events following immunisation: Australia 2002 to 2003
    Glenda Lawrence
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children s Hospital at Westmead, Westmead, New South Wales
    Commun Dis Intell Q Rep 28:324-38. 2004
    ..The low reporting rate of serious AEFIs demonstrates the high level of safety of vaccines in Australia...
  9. ncbi request reprint Annual report: Surveillance of adverse events following immunisation in Australia, 2005
    Glenda Lawrence
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children s Hospital at Westmead, Sydney, New South Wales
    Commun Dis Intell Q Rep 30:319-33. 2006
    ..The consistently low reporting rate of serious AEFIs demonstrates the high level of safety of vaccines in Australia...
  10. ncbi request reprint Annual report: surveillance of adverse events following immunisation in Australia, 2008
    Rob Menzies
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney, The Children s Hospital at Westmead, Sydney, New South Wales
    Commun Dis Intell Q Rep 33:365-81. 2009
    ..The consistently low reporting rate of serious AEFI highlights the safety of vaccines in Australia and illustrates the value of the national TGA database as a surveillance tool for monitoring AEFIs nationally...
  11. ncbi request reprint Vaccination for the paediatrician
    Nicholas Wood
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead and the University of Sydney, Department of Allergy, Immunology and Infectious Diseases, NSW, Australia
    J Paediatr Child Health 42:665-73. 2006
    ..The first part of this article discusses groups with special vaccination requirements. The second part discusses the use of individual vaccines in these children...
  12. ncbi request reprint Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccination
    Veronica Kolos
    University of Sydney, Australia
    Vaccine 25:588-90. 2007
    ..These data suggest that residence in a remote area, as a proxy for poorer living conditions for indigenous people, and delayed vaccination, both contribute to higher pertussis hospitalization rates in indigenous infants...
  13. ncbi request reprint Vaccine preventable diseases and vaccination policy for indigenous populations
    Robert Menzies
    The National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Sydney, New South Wales, Australia
    Epidemiol Rev 28:71-80. 2006
    ..In national programs targeting only indigenous people, it has been difficult to achieve high coverage, particularly in urban areas. Innovative program approaches are particularly needed in these situations...
  14. ncbi request reprint Trends in invasive Haemophilus influenzae type B disease in Australia, 1995-2005
    Han Wang
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children s Hospital at Westmead, New South Wales
    Commun Dis Intell Q Rep 32:316-25. 2008
    ..Continued enhanced surveillance for invasive Hib disease is important for optimal monitoring of trends into the future...
  15. doi request reprint Pertussis in infants: preventing deaths and hospitalisations in the very young
    Nicholas Wood
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases NCIRS, Sydney, New South Wales, Australia
    J Paediatr Child Health 44:161-5. 2008
    ....
  16. doi request reprint Implementation of mandatory immunisation of healthcare workers: observations from New South Wales, Australia
    Charles Helms
    University of Sydney, Australia
    Vaccine 29:2895-901. 2011
    ..Vaccines included were measles, mumps, rubella, varicella, hepatitis B, diphtheria, tetanus and pertussis, but not influenza...
  17. ncbi request reprint Cough symptoms in children aged 5-14 years in Sydney, Australia: non-specific cough or unrecognized pertussis?
    Michelle Cagney
    School of Public Health, University of Sydney, Sydney, Australia
    Respirology 10:359-64. 2005
    ..The aim of this study was to estimate the community prevalence of coughing symptoms, consistent with surveillance definitions for pertussis, and doctor-diagnosed pertussis in children aged 5-14 years...
  18. doi request reprint Pertussis: review of epidemiology, diagnosis, management and prevention
    Nicholas Wood
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead, University of Sydney, New South Wales, Australia
    Paediatr Respir Rev 9:201-11; quiz 211-2. 2008
    ..This paper reviews the current epidemiology of pertussis in developed countries, including modes of clinical presentation, diagnosis, management and potential vaccination strategies...
  19. pmc Anaphylaxis following quadrivalent human papillomavirus vaccination
    Julia M L Brotherton
    National Centre for Immunisation Research and Surveillance, The Children s Hospital at Westmead and University of Sydney, NSW, Australia
    CMAJ 179:525-33. 2008
    ..Following notification of 7 presumptive cases of anaphylaxis in the state of New South Wales, Australia, we verified cases and compared the incidence of anaphylaxis following HPV vaccination to other vaccines in comparable settings...
  20. ncbi request reprint Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002
    Robert Menzies
    National Centre for Immunisation Research and Surveillance, The Children s Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145
    Commun Dis Intell Q Rep 28:127-59. 2004
    ..Such issues need to be considered and implemented in full cooperation with Aboriginal and Torres Strait Islander people...
  21. doi request reprint Management of children with otitis media: a summary of evidence from recent systematic reviews
    Hasantha Gunasekera
    Centre for Kidney Research, The Children s Hospital at Westmead, Westmead, NSW, Australia
    J Paediatr Child Health 45:554-62; quiz 562-3. 2009
    ..In this review, we seek to summarise the current best evidence for answering otitis media management questions by collating existing systematic reviews...
  22. ncbi request reprint Vaccine preventable diseases in indigenous populations - International perspectives. Satellite Symposium of the 5th International Symposium on Pneumococci and Pneumococcal Diseases, April 2006, Alice Springs, Australia
    Rob Menzies
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead, Locked Bag 4001, Westmead, New South Wales 2145, Australia
    Vaccine 25:7281-4. 2007
  23. ncbi request reprint Differences in the epidemiology of invasive pneumococcal disease, metropolitan NSW, 1997-2001
    Peter McIntyre
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney, Westmead
    N S W Public Health Bull 14:85-9. 2003
  24. ncbi request reprint Has pertussis increased in NSW over the past decade? An evaluation using hospitalisation and mortality data versus notifications 1988-2002
    Rob Menzies
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney, Westmead
    N S W Public Health Bull 14:71-6. 2003
  25. ncbi request reprint National study of infants hospitalized with pertussis in the acellular vaccine era
    Elizabeth Elliott
    Discipline of Paediatrics and Child Health, The University of Sydney and The Children s Hospital at Westmead, Sydney, Australia
    Pediatr Infect Dis J 23:246-52. 2004
    ..Few data are available on pertussis hospitalizations or sources of infection in countries exclusively using DTPa...
  26. doi request reprint Establishment of a surveillance system (utilising Midwifes Data Collection Systems) for monitoring the impact of hepatitis B vaccination on the population prevalence of chronic hepatitis B virus infection in Australia
    Nicholas Wood
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases NCIRS, Westmead, NSW, Australia
    Aust N Z J Public Health 32:272-5. 2008
    ....
  27. ncbi request reprint Progress towards eliminating Hib in Australia: an evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000
    Peter Horby
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Westmead, NSW
    Commun Dis Intell Q Rep 27:324-41. 2003
    ..Nevertheless, experience in Australia and elsewhere indicates that continued careful monitoring of Hib disease, with high quality laboratory surveillance, remains important...
  28. ncbi request reprint Do variations in pertussis notifications reflect incidence or surveillance practices? A comparison of infant notification rates and hospitalisation data in NSW
    Siranda Torvaldsen
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney, Westmead
    N S W Public Health Bull 14:81-4. 2003
  29. doi request reprint Paediatric active enhanced disease surveillance: a new surveillance system for Australia
    Yvonne Zurynski
    Australian Paediatric Surveillance Unit, Kids Research Institute, The Sydney Children s HospitalsNetwork Westmead, Westmead, NSW 2145, Australia
    J Paediatr Child Health 49:588-94. 2013
    ..PAEDS is active in four tertiary children's hospitals in four states of Australia and aims to address gaps in surveillance for severe vaccine-preventable diseases and adverse events following immunisation...
  30. ncbi request reprint A history of adolescent school based vaccination in Australia
    Kirsten Ward
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases NCIRS, The Children s Hospital at Westmead, New South Wales, Australia
    Commun Dis Intell Q Rep 37:E168-74. 2013
    ..Using existing records and the recollection of experts we have compiled a history of school-based vaccination in Australia, primarily focusing on adolescents. ..
  31. doi request reprint Influenza vaccine safety in children less than 5 years old: the 2010 and 2011 experience in Australia
    Nicholas Wood
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, New South Wales, Australia
    Pediatr Infect Dis J 31:199-202. 2012
    ..These data are reassuring for parents and healthcare workers regarding 2011 influenza vaccination in the northern hemisphere...
  32. ncbi request reprint The spectrum and management of otitis media in Australian indigenous and nonindigenous children: a national study
    Hasantha Gunasekera
    Centre for Kidney Research, The Children s Hospital, Westmead, Sydney, Australia
    Pediatr Infect Dis J 26:689-92. 2007
    ..Indigenous children have the highest reported prevalence and severity of otitis media in the world, but whether their clinical management varies accordingly is unknown...
  33. ncbi request reprint Are general practice registrars prepared for immunisation? A cross sectional survey
    Julie Leask
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead, and the University of Sydney, New South Wales
    Aust Fam Physician 33:665-7. 2004
    ..To describe undergraduate formal training on immunisation as remembered by general practice registrars and its perceived helpfulness...
  34. ncbi request reprint Surveillance of adverse events following immunisation: Australia, 2000-2002
    Glenda Lawrence
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children s Hospital at Westmead, and the University of Sydney, New South Wales
    Commun Dis Intell Q Rep 27:307-23. 2003
    ....
  35. ncbi request reprint Public opponents of vaccination: a case study
    Julie Leask
    National Centre for Immunisation Research and Surveillance, Children s Hospital at Westmead, University of Sydney, Locked Bag 4001, Westmead 2145, Australia
    Vaccine 21:4700-3. 2003
    ..We conclude by suggesting how health professionals might respond in the public arena...
  36. ncbi request reprint Australia's notifiable diseases status, 2006: annual report of the National Notifiable Diseases Surveillance System
    Kylie Begg
    Office of Health Protection, Australian Government Department of Health and Ageing, Canberra, Australian Capital Territory
    Commun Dis Intell Q Rep 32:139-207. 2008
    ..There were 19,111 notifications of bloodborne diseases; 8,606 notifications of vectorborne diseases; 1,900 notifications of other bacterial infections; 767 notifications of zoonoses and 3 notifications of quarantinable diseases...
  37. ncbi request reprint Lessons from surveillance; solving the pertussis puzzle
    Peter McIntyre
    N S W Public Health Bull 14:69-71. 2003
  38. ncbi request reprint The cost-effectiveness of pneumococcal conjugate vaccination in Australia
    James R G Butler
    National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia
    Vaccine 22:1138-49. 2004
    ..We undertook an independent economic analysis of PCV7 compared with no vaccination in the non high-risk Australian childhood population using cost-utility and cost-effectiveness measures...
  39. ncbi request reprint Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old
    Robert B Belshe
    Division of Infectious Diseases and Immunology, Saint Louis University, St Louis, Missouri, USA
    J Infect Dis 189:462-70. 2004
    ..PIV3-cp45 vaccine was safe and immunogenic in seronegative children and should be evaluated for efficacy in a phase 3 field trial...
  40. ncbi request reprint Using computer simulations to compare pertussis vaccination strategies in Australia
    Herbert W Hethcote
    Department of Mathematics, University of Iowa, 14 MacLean Hall, Iowa City, IA 52242, USA
    Vaccine 22:2181-91. 2004
    ....
  41. ncbi request reprint Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002
    Julia Brotherton
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases NCIRS
    Commun Dis Intell 28:vii-S116. 2004
  42. ncbi request reprint Pneumococcal disease in Australia: current status and future challenges. A report of the workshop held at the National Centre for Immunisation Research and Surveillance, 8-9 November, 2002
    Paul Roche
    Surveillance and Epidemiology Section, Department of Health and Ageing, Canberra, Australian Capital Territory
    Commun Dis Intell 27:79-84. 2003
    ..Improving the identification of Aboriginal and Torres Strait Islander children is important, especially in urban areas...
  43. ncbi request reprint Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002
    Robert Menzies
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases
    Commun Dis Intell 28:S1-45. 2004
  44. ncbi request reprint Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005
    Julia Brotherton
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases NCIRS
    Commun Dis Intell Q Rep 31:S1-152. 2007
  45. ncbi request reprint Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine
    Terry Nolan
    The University of Melbourne, Department of Paediatrics, and Murdoch Children s Research Institute at the Royal Children s Hospital, Melbourne, Australia
    Vaccine 21:281-9. 2002
    ..This tetravalent MMRV candidate vaccine showed promising results, although further examination of the possible increase in minor fever and decreased varicella immunogenicity should be assessed in future studies...
  46. ncbi request reprint Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000
    Peter McIntyre
    Commun Dis Intell Q Rep . 2002
  47. ncbi request reprint Refusal of parents to vaccinate: dereliction of duty or legitimate personal choice?
    Peter McIntyre
    Med J Aust 178:150-1. 2003
  48. ncbi request reprint Mapping immunisation coverage and conscientious objectors to immunisation in NSW
    Brynley Hull
    National Centre for Immunisation Research, The University of Sydney and The Children s Hospital at Westmead
    N S W Public Health Bull 14:8-12. 2003
  49. pmc Improving uptake of MMR vaccine
    Peter McIntyre
    BMJ 336:729-30. 2008
  50. ncbi request reprint Should dexamethasone be part of routine therapy of bacterial meningitis in industrialised countries?
    Peter McIntyre
    National Centre for Immunisation, Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead, NSW, Australia
    Adv Exp Med Biol 568:189-97. 2005
    ..16). Unless clear protocols are in place, the commencement of steroids before or with antibiotics will be difficult to implement in emergency situations, as illustrated by the data from Sydney...
  51. ncbi request reprint Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain
    Andrew J Culshaw
    Novartis Institutes for BioMedical Research, London WC1E 6BS, UK
    J Med Chem 49:471-4. 2006
    ..We also demonstrate that one compound is active in vivo against capsaicin-induced hyperalgesia and in models of neuropathic and nociceptive pain in the rat...
  52. ncbi request reprint Universal varicella vaccination. Comment
    Kristine Macartney
    Med J Aust 183:278-9. 2005
  53. ncbi request reprint Cloning and functional characterization of the guinea pig vanilloid receptor 1
    Jonathan Savidge
    Novartis Institute for Medical Sciences, 5 Gower Place, WC1E 6BN, London, UK
    Neuropharmacology 43:450-6. 2002
    ..5, and provided complete blockade of heat responses at 1 micro M. Thus, capsazepine can significantly inhibit calcium influx due to heat and pH 5.5 at guinea pig VR1 and human VR1 but is inactive against these activators at rat VR1...